What is Microprobes?
Microprobes for Life Science operates at the intersection of advanced engineering and biological research, providing critical infrastructure for electrophysiology studies. The firm specializes in the design and manufacturing of high-precision microelectrodes and microelectrode arrays, which are essential for both in vivo and in vitro experimental environments. By offering a comprehensive suite of metal microelectrodes, optogenetic arrays, and neural interfaces, the company supports the global scientific community in conducting complex chronic and acute neural recording and stimulation experiments. Their commitment to technical excellence and bespoke research solutions has established them as a foundational partner for laboratories focused on mapping neural pathways and advancing brain-machine interface technologies.
How much funding has Microprobes raised?
Microprobes has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Microprobes
PPP
Public-Private Partnership
What's next for Microprobes?
With this late-stage financing secured, Microprobes is well-positioned to accelerate its research and development pipeline, likely focusing on the miniaturization of neural interfaces and the expansion of its optogenetic product portfolio. The strategic allocation of this capital will likely prioritize global market penetration and the enhancement of technical support infrastructure to meet the increasing demand for high-fidelity neural data acquisition. As the company moves forward, it is expected to leverage its established reputation to capture a larger share of the burgeoning neuro-technology market, potentially exploring new applications in clinical diagnostics and therapeutic stimulation devices.
See full Microprobes company page
